Proto Labs, Inc.
NYSE:PRLB
39.25 (USD) • At close January 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 503.877 | 488.398 | 488.098 | 434.395 | 458.728 | 445.596 | 344.49 | 298.055 | 264.106 | 209.583 | 163.112 | 125.991 | 98.939 | 64.919 | 43.833 |
| Cost of Revenue
| 281.884 | 272.933 | 265.407 | 216.568 | 223.438 | 206.917 | 150.648 | 131.118 | 109.703 | 81.182 | 61.41 | 49.853 | 39.324 | 25.443 | 18.559 |
| Gross Profit
| 221.993 | 215.465 | 222.691 | 217.827 | 235.29 | 238.679 | 193.842 | 166.937 | 154.403 | 128.401 | 101.702 | 76.138 | 59.615 | 39.476 | 25.274 |
| Gross Profit Ratio
| 0.441 | 0.441 | 0.456 | 0.501 | 0.513 | 0.536 | 0.563 | 0.56 | 0.585 | 0.613 | 0.624 | 0.604 | 0.603 | 0.608 | 0.577 |
| Reseach & Development Expenses
| 40.135 | 38.222 | 44.241 | 36.94 | 32.692 | 28.735 | 23.56 | 22.388 | 18.35 | 16.607 | 11.863 | 9.137 | 5.222 | 4.281 | 3.14 |
| General & Administrative Expenses
| 65.788 | 67.544 | 55.933 | 51.742 | 49.766 | 52.513 | 41.2 | 36.651 | 29.716 | 22.122 | 16.154 | 13.957 | 11.772 | 7.629 | 5.965 |
| Selling & Marketing Expenses
| 87.688 | 82.752 | 82.175 | 69.309 | 72.976 | 68.533 | 56.856 | 46.131 | 39.188 | 29.144 | 22.386 | 18.098 | 15.752 | 10.867 | 8.262 |
| SG&A
| 153.476 | 150.296 | 138.108 | 121.051 | 122.742 | 121.046 | 98.056 | 82.782 | 68.904 | 51.266 | 38.54 | 32.055 | 27.524 | 18.496 | 14.227 |
| Other Expenses
| 0.215 | 0.106 | -0.158 | 3.109 | 1.337 | 2.757 | 2.209 | 2.454 | 0.712 | 0.003 | 0.279 | 0.023 | 0 | 0 | 0 |
| Operating Expenses
| 193.826 | 188.518 | 182.349 | 157.991 | 155.434 | 149.781 | 121.616 | 105.17 | 87.254 | 67.873 | 50.403 | 41.192 | 32.746 | 22.777 | 17.367 |
| Operating Income
| 28.167 | 151.877 | 40.342 | 59.836 | 79.856 | 88.898 | 72.226 | 61.767 | 67.149 | 60.528 | 51.299 | 34.946 | 26.869 | 16.699 | 7.907 |
| Operating Income Ratio
| 0.056 | 0.311 | 0.083 | 0.138 | 0.174 | 0.2 | 0.21 | 0.207 | 0.254 | 0.289 | 0.315 | 0.277 | 0.272 | 0.257 | 0.18 |
| Total Other Income Expenses Net
| -0.215 | 0.106 | -0.158 | 3.109 | 1.337 | 2.757 | 2.209 | 2.454 | 0.712 | 0.003 | 0.279 | 0.023 | -0.114 | -0.986 | -0.517 |
| Income Before Tax
| 27.952 | -97.877 | 40.184 | 62.945 | 81.193 | 91.655 | 74.435 | 64.221 | 67.861 | 60.531 | 51.578 | 34.969 | 26.755 | 15.713 | 7.39 |
| Income Before Tax Ratio
| 0.055 | -0.2 | 0.082 | 0.145 | 0.177 | 0.206 | 0.216 | 0.215 | 0.257 | 0.289 | 0.316 | 0.278 | 0.27 | 0.242 | 0.169 |
| Income Tax Expense
| 10.732 | 5.585 | 6.812 | 12.078 | 17.538 | 15.067 | 22.657 | 21.514 | 21.347 | 18.896 | 16.301 | 10.944 | 8.783 | 4.762 | 3.167 |
| Net Income
| 17.22 | -103.462 | 33.372 | 50.867 | 63.655 | 76.588 | 51.778 | 42.707 | 46.514 | 41.635 | 35.277 | 24.025 | 17.972 | 10.951 | 4.223 |
| Net Income Ratio
| 0.034 | -0.212 | 0.068 | 0.117 | 0.139 | 0.172 | 0.15 | 0.143 | 0.176 | 0.199 | 0.216 | 0.191 | 0.182 | 0.169 | 0.096 |
| EPS
| 0.66 | -3.77 | 1.21 | 1.9 | 2.37 | 2.84 | 1.94 | 1.62 | 1.79 | 1.62 | 1.4 | 1.03 | 0.4 | 0.24 | 0.002 |
| EPS Diluted
| 0.66 | -3.77 | 1.21 | 1.89 | 2.35 | 2.81 | 1.93 | 1.61 | 1.77 | 1.6 | 1.36 | 0.98 | 0.4 | 0.22 | 0.001 |
| EBITDA
| 66.58 | 66.372 | 80.83 | 92.43 | 110.72 | 115.652 | 90.7 | 79.252 | 81.275 | 71.666 | 58.868 | 41.026 | 31.247 | 21.168 | 11.331 |
| EBITDA Ratio
| 0.132 | 0.392 | 0.166 | 0.213 | 0.241 | 0.26 | 0.263 | 0.266 | 0.308 | 0.342 | 0.361 | 0.326 | 0.316 | 0.326 | 0.259 |